By Mill Chart
Last update: May 29, 2024
Discover VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX), an undervalued growth gem identified by our stock screener. NASDAQ:VRTX is shining in terms of growth metrics, and it's also displaying strong financial health and profitability. What's more, it retains an appealing valuation. We'll break it down further.
ChartMill assigns a Growth Rating to each stock, ranging from 0 to 10. This rating is determined by analyzing different growth elements, including EPS and revenue growth, spanning both historical and future figures. In the case of NASDAQ:VRTX, the assigned 7 reflects its growth potential:
ChartMill employs its own Valuation Rating system for all stocks. This score, ranging from 0 to 10, is determined by evaluating different valuation factors, including price to earnings and free cash flow, both in absolute terms and relative to the market and industry. NASDAQ:VRTX has earned a 5 for valuation:
ChartMill employs a unique Health Rating system for all stocks. This rating, ranging from 0 to 10, is determined by analyzing various liquidity and solvency ratios. For NASDAQ:VRTX, the assigned 7 for health provides valuable insights:
ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For NASDAQ:VRTX, the assigned 8 is a significant indicator of profitability:
Every day, new Affordable Growth stocks can be found on ChartMill in our Affordable Growth screener.
For an up to date full fundamental analysis you can check the fundamental report of VRTX
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.
436
+1.97 (+0.45%)
Find more stocks in the Stock Screener
Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session.
Stay informed about the performance of the S&P500 index in the middle of the day on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.
Wall Street Retreats as Pharma Stocks Tumble and Trade Uncertainty Lingers
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Curious about the market action on Tuesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.
The regular session of the US market on Monday is now over, but let's get a preview of the after-hours session and explore the top S&P500 gainers and losers driving the post-market movements.